|
US6440455B1
(en)
|
1997-09-02 |
2002-08-27 |
Children's Medical Center Corporation |
Methods for modulating the axonal outgrowth of central nervous system neurons
|
|
CA2348871C
(en)
*
|
1998-11-02 |
2009-04-14 |
John G. Devane |
Multiparticulate modified release composition
|
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
|
US7582680B1
(en)
|
1998-11-12 |
2009-09-01 |
Purdue Research Foundation |
Methods and compositions for treating mammalian spinal cord injuries
|
|
US7172871B1
(en)
*
|
2000-09-07 |
2007-02-06 |
Children's Medical Center Corporation |
Methods and compositions for modulating axonal outgrowth of central nervous system neurons
|
|
FR2814077A1
(fr)
*
|
2000-09-20 |
2002-03-22 |
Inst Nat Sante Rech Med |
Utilisation de modulateurs de recepteurs a l'adenosine pour reguler la fonction des netrines et/ou de leurs recepteurs
|
|
US7981420B2
(en)
|
2000-12-22 |
2011-07-19 |
Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. |
Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)
|
|
AU2002314758B2
(en)
|
2001-04-24 |
2006-06-01 |
Purdue Research Foundation |
Method and composition for treating mammalian nerve tissue injuries
|
|
US7147647B2
(en)
*
|
2002-04-26 |
2006-12-12 |
Medtronic, Inc. |
Sintered titanium tube for the management of spinal cord injury
|
|
US20040106896A1
(en)
*
|
2002-11-29 |
2004-06-03 |
The Regents Of The University Of California |
System and method for forming a non-ablative cardiac conduction block
|
|
US7813473B2
(en)
*
|
2002-07-23 |
2010-10-12 |
General Electric Company |
Method and apparatus for generating temporally interpolated projections
|
|
US6904118B2
(en)
*
|
2002-07-23 |
2005-06-07 |
General Electric Company |
Method and apparatus for generating a density map using dual-energy CT
|
|
CA2497437A1
(en)
*
|
2002-09-03 |
2004-03-18 |
Neurological Technologies Inc. |
Purine nucleosides as anti-apoptotic agents
|
|
JP2006501936A
(ja)
*
|
2002-10-04 |
2006-01-19 |
エラン ファーマ インターナショナル，リミティド |
固体ナノ粒子活性薬剤のガンマ線照射
|
|
GB0228723D0
(en)
|
2002-12-09 |
2003-01-15 |
Cambridge Biotechnology Ltd |
Treatment of pain
|
|
AU2003300012A1
(en)
*
|
2002-12-30 |
2004-07-29 |
Indiana University Research & Technology Corporation |
Method of treatment for central nervous system injury
|
|
CA2523035C
(en)
*
|
2003-05-22 |
2011-04-26 |
Elan Pharma International Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
|
GB0312844D0
(en)
*
|
2003-06-04 |
2003-07-09 |
Paradigm Therapeutics Ltd |
Use of compounds in medicine
|
|
WO2005016359A1
(en)
*
|
2003-08-19 |
2005-02-24 |
Neurological Technologies Inc. |
Method of promoting remyelination
|
|
US8912144B2
(en)
*
|
2003-12-16 |
2014-12-16 |
Children's Medical Center Corporation |
Method for treating stroke via administration of NEP1-40 and inosine
|
|
US20080113016A1
(en)
*
|
2004-07-26 |
2008-05-15 |
Gary Steven Firestein |
Method for Prevention or Treatment of Inflammatory Disease
|
|
WO2006023530A2
(en)
*
|
2004-08-16 |
2006-03-02 |
Massachusetts Institute Of Technology |
Compositions and methods for enhancing structural and functional nervous system reorganization and recovery
|
|
EP1855651A4
(en)
*
|
2005-03-03 |
2011-06-15 |
Elan Pharma Int Ltd |
NANOPARTICLE COMPOSITIONS OF HETEROCYCLIC AMID DERIVATIVES
|
|
WO2006111348A1
(de)
*
|
2005-04-18 |
2006-10-26 |
Abbott Gmbh & Co. Kg |
Verwendung von heparin und heparinderivaten zur modulation des neuritenwachstum-kontrollierenden nogo-rezeptors
|
|
WO2007039256A2
(de)
|
2005-09-30 |
2007-04-12 |
Abbott Gmbh & Co. Kg |
Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
|
|
RU2008143202A
(ru)
*
|
2006-03-31 |
2010-05-10 |
Аденобио Н.В. (Nl) |
Композиции, способы и наборы с использованием аденозина и инозина в комбинации для диагностики и лечения
|
|
BRPI0714173A2
(pt)
*
|
2006-07-12 |
2012-12-25 |
Elan Pharma Int Ltd |
composiÇço nanoparticulada estÁvel,mÉtodos para preparar a composiÇço, para prevenir e/ou tratar estados de doenÇas, sintomas, sÍndromes e condiÇÕes do sistema nervoso central, para melhorar ou manter a biodisponibilidade de modafinil, e para tratar distérbio com base neurolàgica, composiÇço farmacÊutica, e forma de dosagem
|
|
US8419710B2
(en)
*
|
2006-12-06 |
2013-04-16 |
Medtronic, Inc. |
Methods for infusing fluids via an implantable infusion system
|
|
US20080270686A1
(en)
*
|
2007-04-26 |
2008-10-30 |
Grannan Michael F |
Methods and system to cache content on a vehicle
|
|
WO2009111264A2
(en)
*
|
2008-02-29 |
2009-09-11 |
Alseres Pharmaceuticals, Inc. |
Systemic purine administration:modulating axonal outgrowth of central nervous system neurons
|
|
US8962803B2
(en)
*
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
|
DK2502623T3
(en)
|
2008-06-06 |
2016-07-04 |
Children's Medical Center Corp |
Promoting axonregeneration the adult cns by management of protein translation
|
|
BR112012013734A2
(pt)
|
2009-12-08 |
2017-01-10 |
Abbott Gmbh & Co Kg |
anticorpos monoclonais contra a proteína rgm a para uso no tratamento da degeneração da camada de fibras nervosas da retina.
|
|
SG11201404263TA
(en)
|
2012-01-27 |
2014-08-28 |
Abbvie Deutschland |
Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
|
|
US20140179741A1
(en)
*
|
2012-10-10 |
2014-06-26 |
Massachusetts Institute Of Technology |
Use of chelators of divalent cations to promote nerve regeneration
|
|
WO2014096958A1
(en)
*
|
2012-11-02 |
2014-06-26 |
Academisch Medisch Centrum |
Inosine monophosphate and salts thereof for use in the treatment of complement-related disorders
|
|
RU2517117C2
(ru)
*
|
2012-11-26 |
2014-05-27 |
Государственное бюджетное образовательное учреждение высшего профессионального образования "Казанский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО Казанский ГМУ Минздравсоцразвития России) |
Способ стимулирования регенерации нерва с помощью наноструктурированного матрикса и генетических конструкций
|
|
RU2728722C2
(ru)
*
|
2015-08-26 |
2020-07-30 |
Стаджен Ко., Лтд. |
Усилитель внутриклеточного атф
|
|
WO2020140730A1
(zh)
*
|
2018-12-30 |
2020-07-09 |
广州君赫生物科技有限公司 |
硫鸟嘌呤在制备治疗adsl缺陷症药物中应用
|
|
EP3797764A1
(en)
|
2019-09-27 |
2021-03-31 |
Janusz Chupty Contissi |
Pharmacological composition for treatment of nervous tissue dysfunction, in particular viral latency, and the use of j05 atc group substances in treatment of nervous tissue dysfunction, in particular viral latency
|
|
WO2021260740A1
(en)
*
|
2020-06-25 |
2021-12-30 |
Celagenex Research (India) Pvt. Ltd. |
Novel synergistic nutritional compositions for promoting axonal regeneration
|
|
WO2023055531A1
(en)
*
|
2021-09-28 |
2023-04-06 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods for treating peripheral neuropathy
|